Dermatitis - Esthetician Leadership Today

Why Allergic Atopic Dermatitis is Underdiagnosed

MedEsthetics

OCTOBER 23, 2023

The study in the Journal of the American Academy of Dermatology indicates that allergic contact dermatitis has similar symptoms and can be triggered by a range of substances, causing it to be underdiagnosed.

Dermatitis

Dermatitis Dermatology

Plasma Protein Analysis Identifies New Drug Targets for Atopic Dermatitis

Dermatology Times

DECEMBER 6, 2024

A study using proteome-wide association techniques identified novel protein biomarkers for atopic dermatitis.

Dermatitis

Don’t Forget to Address Autoimmune Comorbidities of Atopic Dermatitis

Dermatology Times

JUNE 9, 2024

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

Dermatitis

Dupilumab for Atopic Dermatitis: 7 Years Later

Dermatology Times

MARCH 28, 2024

Today officially marks 7 years since the US FDA approved dupilumab for the treatment of atopic dermatitis. Here's a look back at its approval timeline and all it has accomplished in the dermatology world in the time since.

Dermatitis

Dermatitis Dermatology Treatments

Understanding The Heterogenous Nature of Atopic Dermatitis

Dermatology Times

APRIL 5, 2024

Mark Lebwohl, MD, emphasizes the importance of considering various factors, including severity of itch and interference with sleep, when determining treatments for patients with atopic dermatitis, even with presentation may not include typical symptoms.

Dermatitis

Dermatitis Treatments

Looking Ahead to Advancements in Vitiligo and Atopic Dermatitis

Dermatology Times

JUNE 10, 2024

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

Dermatitis

Unraveling the Advancements in Seborrheic Dermatitis Treatment

Dermatology Times

JUNE 1, 2024

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

Dermatitis

Dermatitis Treatments

Exploring New Pathways in Atopic Dermatitis

Dermatology Times

JUNE 10, 2024

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

Dermatitis

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 1

Dermatology Times

MAY 7, 2024

A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.

Dermatitis

Dermatitis Clinic Treatments

Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms

Dermatology Times

APRIL 12, 2024

Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.

Dermatitis

Dermatitis Treatments Safety Management

Prioritizing Itch and Sleep Improvement in Atopic Dermatitis

Dermatology Times

JUNE 11, 2024

Gil Yosipovitch, MD, addresses the severity of chronic itch and sleep disturbances in patients with atopic dermatitis.

Dermatitis

Roflumilast Foam, 0.3% for Seborrheic Dermatitis Launches in US

Dermatology Times

JANUARY 22, 2024

Zoryve was approved for the treatment of seborrheic dermatitis in patients ages 9 years and older in December.

Dermatitis

Dermatitis Treatments

The Relationship Between Alcohol Consumption and Atopic Dermatitis

Dermatology Times

JANUARY 9, 2024

Test your knowledge and explore a recent study on the relationship between alcohol consumption and skin diseases, including atopic dermatitis.

Dermatitis

Should Malassezia’s Role in Seborrheic Dermatitis Be Reconsidered?

Dermatology Times

MAY 30, 2024

Raj Chovatiya, MD, PhD, reviews the varying degrees of influence of skin barrier disruption, immune dysregulation, and Malassezia yeast in seborrheic dermatitis.

Dermatitis

Silver Linings With the Silverbergs: Showcasing Vitiligo and Atopic Dermatitis Research

Dermatology Times

JANUARY 11, 2024

Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.

Dermatitis

Dermatitis Innovations Treatments

Abby L. Allen, RN, NP: Update on Biologics for Atopic Dermatitis

Dermatology Times

NOVEMBER 12, 2023

What are some of the challenges and triumphs in using biologics for atopic dermatitis? Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.

Dermatitis

Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine

Dermatology Times

APRIL 18, 2024

Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted.

Dermatitis

Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis

Dermatology Times

JULY 13, 2024

Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.

Dermatitis

Dermatitis Innovations

The Cutaneous Connection: Decoding Atopic Dermatitis at AAD

Dermatology Times

MARCH 4, 2024

Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition.

Dermatitis

Dermatitis Education Dermatology

Understanding Biologic Options in Atopic Dermatitis Management

Dermatology Times

NOVEMBER 4, 2023

Test your knowledge on approved biologics in the management of moderate to severe atopic dermatitis and considerations for an 18-year-old man's case.

Dermatitis

Dermatitis Management

Association Found Between Atopic Dermatitis and Altered Oral Microbiome

Dermatology Times

DECEMBER 11, 2023

A poster from the 2023 Revolutionizing Atopic Dermatitis Conference revealed a link between AD, impaired oral health, and oral dysbiosis.

Dermatitis

Caregivers and Patients With Atopic Dermatitis Prioritize Symptom Control, Adverse Effect Management

Dermatology Times

JANUARY 23, 2024

A study explored the prioritization habits of both patients with atopic dermatitis and their caregivers when it comes to treatment.

Dermatitis

Dermatitis Management Treatments

Reflecting On 10 Years of Atopic Dermatitis Research

Dermatology Times

SEPTEMBER 6, 2023

As we approach National Eczema Week and National Eczema Month, take a look at the most influential atopic dermatitis research from the last decade.

Dermatitis

Dermatitis Eczema

The Road to Relief: Navigating a Personal Atopic Dermatitis Journey

Dermatology Times

JUNE 11, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses the atopic dermatitis patient experience alongside one of her patients, Mickey Bryson.

Dermatitis

FDA Updates Dupilumab Label With Hand, Foot Atopic Dermatitis Involvement

Dermatology Times

JANUARY 16, 2024

The FDA has added efficacy and safety data for patients ages 12 years and older with uncontrolled moderate-to-severe atopic dermatitis with hand and/or foot involvement.

Dermatitis

Dermatitis Safety

Concerto Biosciences Doses First Participant in Phase 1 Trial of ENS-002, a Microbiome-Based Therapy for Atopic Dermatitis

Dermatology Times

NOVEMBER 20, 2024

aureus in atopic dermatitis. ENS-002 targets S.

Dermatitis

Dermatitis Therapy

Clinical Features and Cytokine Pathways in Prurigo Nodularis vs Atopic Dermatitis

Dermatology Times

OCTOBER 3, 2024

Jason Hawkes, MD, MS, emphasized the importance of biologic treatments transforming the management of both prurigo nodularis and atopic dermatitis.

Dermatitis

Dermatitis Clinic Management Treatments

Addressing Mental Health Issues in Patients with Atopic Dermatitis

Dermatology Times

NOVEMBER 10, 2023

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis.

Dermatitis

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

Dermatology Times

SEPTEMBER 30, 2023

Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.

Dermatitis

Dermatitis Treatments

Atopic Dermatitis Itch May Be Caused by Microbes, Not Inflammation

Dermatology Times

FEBRUARY 23, 2024

Researchers have found Staphylococcus aureus may trigger itchiness in atopic dermatitis, opening the door to new treatment approaches in the future.

Dermatitis

Dermatitis Treatments

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

Dermatology Times

OCTOBER 1, 2023

October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.

Dermatitis

Dermatitis Eczema Dermatology

Patient Perspective: I Am More Than My Atopic Dermatitis

Dermatology Times

DECEMBER 11, 2023

Jennifer Etienne shared her experiences during the shared decision-making patient panel of the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Dermatitis

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 2

Dermatology Times

MAY 14, 2024

A 5-expert panel continues their conversation on atopic dermatitis, exploring beyond steroids and addressing unmet needs.

Dermatitis

Dermatitis Clinic Treatments

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

Dermatology Times

MAY 21, 2024

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.

Dermatitis

Dermatitis Clinic Treatments

FDA Approves Historic Roflumilast Foam 0.3% For Seborrheic Dermatitis

Dermatology Times

DECEMBER 15, 2023

is the first FDA-approved drug for seborrheic dermatitis with a new mechanism of action in over 2 decades. Roflumilast foam 0.3% Christopher Bunick, MD, PhD; Shawn Kwatra, MD; and Peter Lio, MD, share expert insights.

Dermatitis

Alexander Egeberg, MD, PhD, Shares Key Findings on Chronic Hand Eczema and Atopic Dermatitis

Dermatology Times

OCTOBER 31, 2024

Egeberg discusses promising new treatments and insights from recent clinical trials, highlighting significant advancements in chronic hand eczema and atopic dermatitis care presented at the EADV 2024.

Eczema

Eczema Dermatitis Clinic Treatments

Expert Insights: Unmet Needs in Topical Treatment for Atopic Dermatitis

Dermatology Times

APRIL 12, 2024

Linda Stein-Gold, MD, and Michael Cameron, MD, FAAD, discuss the need for non-steroidal treatment options in atopic dermatitis management, driven by patient preferences.

Dermatitis

Dermatitis Treatments Irritation Management

Viewing Atopic Dermatitis and Its Impact From a Patient Perspective

Dermatology Times

OCTOBER 11, 2023

Dermatologist Diego Ruiz Dasilva, MD, FAAD, and a patient with atopic dermatitis discuss the patient journey from initial symptoms to diagnosis to treatment selection.

Dermatitis

Dermatitis Treatments

Key Considerations for Optimal Atopic Dermatitis Care Across All Ages

Dermatology Times

NOVEMBER 21, 2023

From the November cover: Raj Chovatiya, MD, PhD, and Lawrence Eichenfield, MD, shared their insights and key treatment pearls into atopic dermatitis management for adults and children.

Dermatitis

Dermatitis Management Treatments

Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis

Dermatology Times

APRIL 24, 2024

Posters from the Academy of Managed Care Pharmacy annual meeting featured studies on atopic dermatitis.

Dermatitis

Dermatitis Management Education

Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of Color

Dermatology Times

DECEMBER 5, 2023

Zakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.

Dermatitis

Dermatitis Dermatology

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Dermatology Times

NOVEMBER 6, 2023

In this episode, discover and learn how to address the unique challenges faced by college students diagnosed with atopic dermatitis—especially as they navigate new lifestyles and medication management.

Dermatitis

Dermatitis Management Medical

New Phase 3 Data on Long-Term Efficacy of Upadacitinib in Atopic Dermatitis Presented at EADV

Dermatology Times

OCTOBER 11, 2023

The data presents compelling evidence for the sustained efficacy and safety of the oral JAK1 inhibitor in the treatment of moderate to severe atopic dermatitis over an extended 140-week period.

Dermatitis

Dermatitis Sustainability Safety Treatments

The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

Dermatology Times

OCTOBER 5, 2023

Colleen Cotton, MD, discusses the treatment landscape of pediatric atopic dermatitis, highlights from her session at Maui Derm NP+PA in Asheville, NC, and more.

Dermatitis

Dermatitis Therapy Treatments

Why Allergic Atopic Dermatitis is Underdiagnosed

Plasma Protein Analysis Identifies New Drug Targets for Atopic Dermatitis

Trending Sources

Don’t Forget to Address Autoimmune Comorbidities of Atopic Dermatitis

Dupilumab for Atopic Dermatitis: 7 Years Later

Understanding The Heterogenous Nature of Atopic Dermatitis

Looking Ahead to Advancements in Vitiligo and Atopic Dermatitis

Unraveling the Advancements in Seborrheic Dermatitis Treatment

Exploring New Pathways in Atopic Dermatitis

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 1

Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms

Prioritizing Itch and Sleep Improvement in Atopic Dermatitis

Roflumilast Foam, 0.3% for Seborrheic Dermatitis Launches in US

The Relationship Between Alcohol Consumption and Atopic Dermatitis

Should Malassezia’s Role in Seborrheic Dermatitis Be Reconsidered?

Silver Linings With the Silverbergs: Showcasing Vitiligo and Atopic Dermatitis Research

Abby L. Allen, RN, NP: Update on Biologics for Atopic Dermatitis

Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine

Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis

The Cutaneous Connection: Decoding Atopic Dermatitis at AAD

Understanding Biologic Options in Atopic Dermatitis Management

Association Found Between Atopic Dermatitis and Altered Oral Microbiome

Caregivers and Patients With Atopic Dermatitis Prioritize Symptom Control, Adverse Effect Management

Reflecting On 10 Years of Atopic Dermatitis Research

The Road to Relief: Navigating a Personal Atopic Dermatitis Journey

FDA Updates Dupilumab Label With Hand, Foot Atopic Dermatitis Involvement

Concerto Biosciences Doses First Participant in Phase 1 Trial of ENS-002, a Microbiome-Based Therapy for Atopic Dermatitis

Clinical Features and Cytokine Pathways in Prurigo Nodularis vs Atopic Dermatitis

Addressing Mental Health Issues in Patients with Atopic Dermatitis

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

Atopic Dermatitis Itch May Be Caused by Microbes, Not Inflammation

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

Patient Perspective: I Am More Than My Atopic Dermatitis

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 2

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

FDA Approves Historic Roflumilast Foam 0.3% For Seborrheic Dermatitis

Alexander Egeberg, MD, PhD, Shares Key Findings on Chronic Hand Eczema and Atopic Dermatitis

Expert Insights: Unmet Needs in Topical Treatment for Atopic Dermatitis

Viewing Atopic Dermatitis and Its Impact From a Patient Perspective

Key Considerations for Optimal Atopic Dermatitis Care Across All Ages

Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis

Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of Color

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

New Phase 3 Data on Long-Term Efficacy of Upadacitinib in Atopic Dermatitis Presented at EADV

The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

Stay Connected